Protein Engineering and Immobilization of Imine Reductases for Pharmaceutical Synthesis: Recent Advances and Applications
Chemistry · 28.03.2026 · 8 (4) · 40
DOI: 10.3390/chemistry8040040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry, online erschienen am 28.03.2026. Verfasst von Nevena Kaličanin und 6 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Belgrade https://ror.org/02qsmb048.
Abstract (Originalsprache)
Imine reductases (IREDs) have emerged as valuable biocatalysts for the asymmetric synthesis of chiral amines, key intermediates in numerous active pharmaceutical ingredients. Their ability to operate under mild reaction conditions with high chemo- and stereoselectivity provides an attractive alternative to conventional metal-catalyzed or chemical reduction processes. However, the broader industrial application of wild-type IREDs is often constrained by their limited substrate scope and moderate catalytic efficiency. Recent advances in biocatalysis have demonstrated that engineered IREDs can catalyze the reduction of a wide range of natural and non-natural imines, significantly expanding their applicability in pharmaceutical and fine chemical synthesis. In parallel, enzyme immobilization strategies have proven highly effective for improving operational stability, facilitating enzyme reuse, and enabling continuous flow biocatalytic processes. Efficient cofactor regeneration systems have further enhanced the practical implementation of IRED-based transformations. Advances in protein engineering, including structure-guided design, semi-rational mutagenesis, and directed evolution, have generated enzyme variants with improved catalytic activity, stereoselectivity, and substrate tolerance. The integration of high-throughput screening technologies and machine-learning-assisted enzyme design has further accelerated the discovery and optimization of efficient IRED biocatalysts. This review summarizes recent progress in the protein engineering and immobilization of IREDs and discusses future perspectives for their industrial application.
Förderung
- University of Belgrade https://ror.org/02qsmb048
Zitieren
APA
Kaličanin, N., Kokar, N. P., Savković, M. S., Stošić, A., Prodanović, O., Surudžić, N., & Prodanović, R. (2026). Protein Engineering and Immobilization of Imine Reductases for Pharmaceutical Synthesis: Recent Advances and Applications. Chemistry, 8(4), 40. https://doi.org/10.3390/chemistry8040040
Vancouver
Kaličanin N, Kokar NP, Savković MS, Stošić A, Prodanović O, Surudžić N, et al. Protein Engineering and Immobilization of Imine Reductases for Pharmaceutical Synthesis: Recent Advances and Applications. Chemistry. 2026;8(4):40. doi:10.3390/chemistry8040040
BibTeX
@article{Kalianin2026,
author = {Kaličanin, Nevena and Kokar, Nikolina Popović and Savković, Milica Spasojević and Stošić, Anja and Prodanović, Olivera and Surudžić, Nevena and Prodanović, Radivoje},
title = {Protein Engineering and Immobilization of Imine Reductases for Pharmaceutical Synthesis: Recent Advances and Applications},
journal = {Chemistry},
year = {2026},
volume = {8},
number = {4},
pages = {40},
doi = {10.3390/chemistry8040040}
}
EUVIMED